S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda

Royal Bank of Canada (RY) Stock Forecast & Price Target

$97.86
+0.96 (+0.99%)
(As of 04/19/2024 ET)

Royal Bank of Canada Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Moderate Buy
Based on 6 Analyst Ratings

Analysts' Consensus Price Target

$137.67
40.68% Upside
High Forecast$150.00
Average Forecast$137.67
Low Forecast$124.00
TypeCurrent Forecast
4/22/23 to 4/21/24
1 Month Ago
3/23/23 to 3/22/24
3 Months Ago
1/22/23 to 1/22/24
1 Year Ago
4/22/22 to 4/22/23
Consensus Rating
Moderate Buy
Hold
Hold
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
4 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
1 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$137.67$131.50$131.50$125.00
Predicted Upside40.68% Upside47.83% Upside47.75% Upside20.92% Upside
Get Royal Bank of Canada Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for RY and its competitors with MarketBeat's FREE daily newsletter.

RY Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

RY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Royal Bank of Canada Stock vs. The Competition

TypeRoyal Bank of CanadaFinance CompaniesS&P 500
Consensus Rating Score
2.50
2.44
2.49
Consensus RatingModerate BuyHoldHold
Predicted Upside40.68% Upside74.93% Upside11.96% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
4/5/2024BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeMarket Perform ➝ Outperform$140.00 ➝ $150.00+48.54%
3/20/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageEqual Weight
2/22/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageHold
12/18/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy
8/25/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$138.00 ➝ $139.00+56.43%
5/16/2023CIBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeSector Outperform ➝ Neutral

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 08:07 PM ET.

RY Price Target - Frequently Asked Questions

What is Royal Bank of Canada's consensus rating and price target?

According to the issued ratings of 6 analysts in the last year, the consensus rating for Royal Bank of Canada stock is Moderate Buy based on the current 3 hold ratings and 3 buy ratings for RY. The average twelve-month price prediction for Royal Bank of Canada is $137.67 with a high price target of $150.00 and a low price target of $124.00. Learn more on RY's analyst rating history.

Do Wall Street analysts like Royal Bank of Canada more than its competitors?

Analysts like Royal Bank of Canada more than other Finance companies. The consensus rating for Royal Bank of Canada is Moderate Buy while the average consensus rating for finance companies is Hold. Learn more on how RY compares to other companies.

Is Royal Bank of Canada being upgraded by Wall Street analysts?

Over the previous 90 days, Royal Bank of Canada's stock had 1 upgrade by analysts.

Does Royal Bank of Canada's stock price have much upside?

According to analysts, Royal Bank of Canada's stock has a predicted upside of 46.82% based on their 12-month stock forecasts.

What analysts cover Royal Bank of Canada?

Royal Bank of Canada has been rated by Barclays, BMO Capital Markets, and Jefferies Financial Group in the past 90 days.

Does Royal Bank of Canada rate other companies?

Royal Bank of Canada also publishes sell-side equities research reports and recommendations about other companies, which can be viewed at its brokerage rating page.


Stock Ratings Reports and Tools

This page (NYSE:RY) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners